CONNECTING THE ACADEMIC AND PHARMACEUTICAL
COMMUNITIES IN THE GREATER BOSTON AREA

Merck Research Laboratories is proud to present the inaugural Boston Symposium on Organic and Bioorganic Chemistry September 27-28 at the MRL Boston research facility. This unique, two-day forum will provide an experience for attendees that includes:

  • Keynote presentations from two of the Boston area’s leading academic chemistry researchers.
    Prof. Mohammad Movassaghi, Massachusetts Institute of Technology
    Prof. Gregory L. Verdine, Harvard University
  • Cutting-edge science presentations and poster sessions by local students and professional scientists from world-class academic and industrial institutions.
  • Networking opportunities for students, faculty, and industry scientists.
  • An exciting workshop designed specifically for students interested in understanding how a drug goes from concept to commercialization. The development of Isentress, the first integrase inhibitor approved for the treatment of HIV infection, will be described.

Join us in Boston September 27-28 for this extraordinary opportunity to learn about state-of-the-art research in the fields of organic and bioorganic chemistry and to network with your peers and industry and academic scientists.